Myocardial Infarction News and Research

RSS

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

BioLineRx, a biopharmaceutical drug development company, and Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that they have signed a worldwide, exclusive license agreement for BioLineRx to develop and commercialize BL-7040, an orally available Phase II ready molecule for treating Inflammatory Bowel Disease (IBD) and other inflammatory diseases.

27 Jun 2011

Positive results from Stealth's Bendavia Phase I renal impairment study

Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.

27 Jun 2011

New guide indicates when and how genetic testing is useful for inherited cardiac conditions

While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific genetic abnormalities. When these genetic disorders affect the integrity of the heart's muscle they are known as a "cardiomyopathy"; when the disorder affects the heart's "excitability", it is known as a "channelopathy".

27 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

23 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

22 Jun 2011

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Only about 10 percent of patients with a certain type of heart attack who need to be transferred to another hospital for a PCI are transferred within the recommended time of 30 minutes, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for Heart-type Fatty Acid Binding Protein (H-FABP), to improve the diagnosis and management of patients with suspected acute coronary syndrome (ACS).

From Randox Laboratories Ltd. 20 Jun 2011

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

Among Medicare patients with heart attack in 4 California counties, diversion of ambulance traffic by the nearest emergency department for 12 hours or more was associated with an increased risk of death for up to one year, according to a study in the June 15 issue of JAMA.

13 Jun 2011

New research finds 74% drop in myocardial infarction over 20-year period

Better control of cholesterol levels and blood pressure and a decline in smoking have contributed to a 74% drop in the risk of heart attack among nearly 10,000 civil servants working in London over a 20-year period, according to new research.

9 Jun 2011

Tβ4 activates Akt survival kinase and reduces heart attack damage

RegeneRx Biopharmaceuticals, Inc. has announced that researchers have shown that Tβ4 has more extensive beneficial effects on the myocardium after heart attack than previously reported.

7 Jun 2011

Researchers explore relationship between emotions and poor prognosis in heart disease

Intense distress and fear of dying, which many people experience when suffering the symptoms of a heart attack, are not only fairly common emotional responses but are also linked to biological changes that occur during the event, according to new research published online today in the European Heart Journal.

2 Jun 2011

Appendix and tonsil surgeries before age 20 can increase risk of premature heart attack

The surgical removal of the appendix and tonsils before the age of 20 was associated with an increased risk of premature heart attack in a large population study performed in Sweden. Tonsillectomy increased the risk by 44% (hazard ratio 1.44) and appendectomy by 33% (HR 1.33).

1 Jun 2011

Boston Scientific voluntarily recalls all Cross Coronary Imaging Catheters used in IVUS procedure

Boston Scientific Corporation today announced that it is voluntarily recalling all of its iCross Coronary Imaging Catheters used in intravascular ultrasound imaging in patients who are candidates for transluminal coronary interventional procedures.

30 May 2011

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.

25 May 2011

FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels

Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.

25 May 2011

Global clinical program demonstrates safety of Medtronic Resolute drug-eluting stent

A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.

From Medtronic 21 May 2011

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Six-month results from the BIOSOLVE-I first-in-man (FIM) trial, studying the DRug-Eluting Absorbable Metal Scaffold (DREAMS), demonstrate a high safety profile of the novel device.

19 May 2011

Study explores link between specific temperament traits and clinical events after heart attack

This study explores for the first time the potential predictive power of Cloninger's temperament traits on prognosis in patients after an acute coronary syndrome admission.

19 May 2011

Sensitive troponin assays improve clinical outcome and cardiac patient management

Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary syndromes.

19 May 2011

Myocardial Infarction News and Research

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Positive results from Stealth's Bendavia Phase I renal impairment study

New guide indicates when and how genetic testing is useful for inherited cardiac conditions

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

New research finds 74% drop in myocardial infarction over 20-year period

Tβ4 activates Akt survival kinase and reduces heart attack damage

Researchers explore relationship between emotions and poor prognosis in heart disease

Appendix and tonsil surgeries before age 20 can increase risk of premature heart attack

Boston Scientific voluntarily recalls all Cross Coronary Imaging Catheters used in IVUS procedure

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels

Global clinical program demonstrates safety of Medtronic Resolute drug-eluting stent

Positive six-month results from BIOSOLVE-I FIM trial of DRug-Eluting Absorbable Metal Scaffold device

Study explores link between specific temperament traits and clinical events after heart attack

Sensitive troponin assays improve clinical outcome and cardiac patient management

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News